Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Active not recruiting × Advanced Breast Cancer × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 63 Breast Neoplasms 45 Colorectal Neoplasms 38 Neoplasms 34 Neoplasm Metastasis 27 Multiple Myeloma 25 Melanoma 25 Pancreatic Neoplasms 24 Stomach Neoplasms 22 Squamous Cell Carcinoma of Head and Neck 22 Recurrence 22 Lymphoma, Large B-Cell, Diffuse 22 Prostatic Neoplasms 21 Triple Negative Breast Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Ovarian Neoplasms 20 Lymphoma, Non-Hodgkin 20 Carcinoma, Renal Cell 20 Lung Neoplasms 19 Leukemia, Myeloid, Acute 19 Lymphoma, Follicular 17 Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma 16 Glioblastoma 15 Myelodysplastic Syndromes 14 Carcinoma, Transitional Cell 14 Uterine Cervical Neoplasms 13 Lymphoma, Mantle-Cell 12 Leukemia 12 Colonic Neoplasms 12

Interventions

sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06612203 2025-12-05

WIN-B

MedSIR

Phase 1/2 Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡